Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Butyrophilin-like 9 expression is associated with outcome in lung adenocarcinoma

Fig. 3

mRNA expression level of BTNL9 in pan-cancer and hazard ratio of relapse-free survival and overall survival in LUAD patients. (A) Increased or decreased expression of BTNL9 in various tumors compared with adjacent tissues using the Oncomine database. (B) BTNL9 expression in pan-cancer analysis using TCGA dataset analyzed by TIMER (*P < 0.05, **P < 0.01, ***P < 0.001). (C) BTNL9 expression and hazard ratio of relapse-free survival, and (D) overall survival using the TissGDB database

Back to article page